alanine has been researched along with Stomach Neoplasms in 45 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using PCR based restriction fragment length polymorphism and single strand conformational polymorphism, we determined single nucleotide exchanges in the p16 and cyclin D1 genes among 56 esophageal adenocarcinomas (ADC) arising in Barrett's esophagus, 95 cardiac gastric ADC, and in 191 distal gastric ADC." | 7.73 | Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. ( Gabbert, HE; Geddert, H; Kiel, S; Sarbia, M; Willers, R; Zhang, J; Zotz, RB, 2005) |
| "In this prospective, randomized, multicenter, open-label, and comparative study, patients who had undergone ESD for EGC or gastric adenoma were randomized into groups receiving either rabeprazole monotherapy (10 mg/day, n=64) or a combination of rabeprazole plus rebamipide (300 mg/day, n=66)." | 5.22 | Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy. ( Akahoshi, K; Akiho, H; Aso, A; Harada, N; Iboshi, Y; Ihara, E; Iwasa, T; Nakamura, K; Nakamura, N; Ochiai, T; Ogino, H; Takayanagi, R, 2016) |
| "Using PCR based restriction fragment length polymorphism and single strand conformational polymorphism, we determined single nucleotide exchanges in the p16 and cyclin D1 genes among 56 esophageal adenocarcinomas (ADC) arising in Barrett's esophagus, 95 cardiac gastric ADC, and in 191 distal gastric ADC." | 3.73 | Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. ( Gabbert, HE; Geddert, H; Kiel, S; Sarbia, M; Willers, R; Zhang, J; Zotz, RB, 2005) |
| " No serious adverse events were observed in any of the patients in either group." | 2.80 | Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m ( Azuma, T; Higuchi, K; Iguchi, M; Machida, H; Morita, Y; Naito, Y; Takeuchi, T; Takeuchi, Y; Tamada, T; Tominaga, K; Uedo, N; Yagi, N; Yamao, J; Yazumi, S, 2015) |
| "We examined 90 patients with early gastric cancer who had undergone ESD." | 2.78 | Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. ( Asakuma, Y; Kashida, H; Kawasaki, M; Kudo, M; Matsui, S; Sakurai, T; Takayama, M, 2013) |
| " pylori, especially after MNU administration to promote carcinogenesis and the effects of the long-term administration of rebamipide or nimesulide were evaluated." | 2.42 | Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? ( Cho, SW; Hahm, KB; Han, SU; Kim, DY; Kim, JH; Kim, MW; Kim, YB; Lee, JS; Nahm, KT; Oh, TY; Song, YJ; Surh, YJ; Yoo, BM, 2003) |
| "Improvement of gastritis is expressed not only in quantity but also in quality of gastritis, which is shown as the reduction of iNOS expression in the gastric mucosa." | 2.42 | Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide. ( Haruma, K; Ito, M, 2003) |
| "Globally, gastric cancer is the third most common cancer and the third leading cause of cancer death." | 1.72 | Microbiota and metabolites alterations in proximal and distal gastric cancer patients. ( Chen, X; Chen, Y; Dai, D; Huang, Y; Jin, W; Lin, W; Teng, L; Wang, H; Wang, W; Yang, Y; Zhang, H; Zhang, J; Zhang, Y, 2022) |
| "There were significant differences in gastric cancer incidence rates according to age, sex, and initial diagnosis at the time of index ESD." | 1.51 | Chemopreventive Effect of Rebamipide against Gastric Cancer in Patients who undergo Endoscopic Resection for Early Gastric Neoplasms: A Nationwide Claims Study. ( Lee, H; Seo, GH, 2019) |
| "MNNG-induced carcinogenesis and may also inhibit progression of cancer in rats." | 1.42 | Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. ( Ebi, M; Hayashi, N; Joh, T; Katano, T; Kataoka, H; Mizoshita, T; Mori, Y; Ozeki, K; Shimura, T; Tanida, S; Tatematsu, M; Tsukamoto, H; Tsukamoto, T, 2015) |
| "Mass screening for gastric cancer (GC), particularly using endoscopy, may not be the most practical approach as a result of its high cost, lack of acceptance, and poor availability." | 1.40 | Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling. ( Bang, EJ; Cho, SI; Hwang, GS; Jang, YJ; Jung, J; Jung, Y; Kwak, JM; Park, S; Ryu, DH, 2014) |
| "pylori obtained from gastric cancer patients secreted Tip alpha in significantly higher amounts than did H." | 1.35 | TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells. ( Fujiki, H; Hayashi, T; Imai, K; Kuzuhara, T; Matsumoto, H; Nishizono, A; Ogawa, T; Ono, Y; Suganuma, M; Yamaguchi, K, 2008) |
| "Its effect on gastric cancer cell growth and its regulatory mechanisms remain unknown." | 1.34 | Rebamipide inhibits gastric cancer cell growth. ( Arakawa, T; Pai, R; Tanigawa, T; Tarnawski, AS, 2007) |
| "We examined in human gastric cancer AGS cells: (1) survivin expression, (2) localization of survivin and Aurora-B, (3) cell proliferation, and (4) effects of specific survivin siRNA and/or rebamipide (free radical scavenging drug) on survivin and Aurora-B expression and cell proliferation." | 1.33 | Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B. ( Chai, J; Chiou, SK; Chu, EC; Pai, R; Tarnawski, A, 2005) |
| "In specimens (Borrmann type III) with tubular adenocarcinoma, resonance peaks were observed at 1." | 1.32 | Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma. ( Cha, SS; Cho, JY; Choi, KS; Eun, CK; Kim, J; Lee, J; Lee, SY; Mun, CW; Nam, SH; Shin, WJ; Yang, YI, 2004) |
| "We have recently reported that a gastric cancer cell line, MKN45, produced a massive amount of IL-8 upon coculture with live H." | 1.30 | Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. ( Aihara, M; Azuma, A; Funakoshi, Y; Imagawa, K; Kikuchi, M; Matsushima, K; Mukaida, N; Ohmoto, Y; Shindo, Y; Takizawa, H; Tsuchimoto, D, 1998) |
| "In lung cancer tissue, the activity of aminopeptidase toward L-leucinamide was abnormally low, while the activity of arylamidase toward L-leucyl-beta-napthylamide was similar to that in normal lung." | 1.25 | Aminopeptidases and arylamidases in normal and cancer tissues in humans. ( Arima, T; Fujii, S; Niinobe, M; Okuda, H; Tamura, Y, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (13.33) | 18.7374 |
| 1990's | 5 (11.11) | 18.2507 |
| 2000's | 11 (24.44) | 29.6817 |
| 2010's | 18 (40.00) | 24.3611 |
| 2020's | 5 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, Q | 1 |
| Deng, D | 1 |
| Pan, C | 1 |
| Ren, J | 1 |
| Wei, T | 1 |
| Wu, Z | 1 |
| Zhang, B | 1 |
| Li, S | 2 |
| Yin, P | 1 |
| Shang, D | 1 |
| Yang, Y | 2 |
| Dai, D | 1 |
| Jin, W | 1 |
| Huang, Y | 1 |
| Zhang, Y | 1 |
| Chen, Y | 1 |
| Wang, W | 1 |
| Lin, W | 1 |
| Chen, X | 2 |
| Zhang, J | 3 |
| Wang, H | 1 |
| Zhang, H | 1 |
| Teng, L | 1 |
| Liu, C | 1 |
| Zheng, Q | 1 |
| Zhao, L | 1 |
| Kong, PF | 1 |
| Yang, H | 1 |
| Liu, X | 1 |
| Jung, DH | 1 |
| Park, JC | 1 |
| Lee, YC | 2 |
| Lee, SK | 1 |
| Shin, SK | 1 |
| Chung, H | 1 |
| Park, JJ | 1 |
| Kim, JH | 4 |
| Youn, YH | 1 |
| Park, H | 1 |
| Lee, JS | 2 |
| Jeon, SW | 1 |
| Lee, HS | 1 |
| Kwon, YH | 1 |
| Nam, SY | 1 |
| Bae, HI | 1 |
| Seo, AN | 1 |
| Videira, RA | 1 |
| Andrade, PB | 1 |
| Monteiro, LS | 1 |
| Valentão, P | 1 |
| Ferreira, PMT | 1 |
| Pereira, DM | 1 |
| Ichida, T | 1 |
| Ueyama, S | 1 |
| Eto, T | 1 |
| Kusano, F | 1 |
| Sakai, Y | 2 |
| Seo, GH | 1 |
| Lee, H | 1 |
| Takayama, M | 1 |
| Matsui, S | 1 |
| Kawasaki, M | 1 |
| Asakuma, Y | 1 |
| Sakurai, T | 1 |
| Kashida, H | 1 |
| Kudo, M | 1 |
| Jung, J | 1 |
| Jung, Y | 1 |
| Bang, EJ | 1 |
| Cho, SI | 1 |
| Jang, YJ | 1 |
| Kwak, JM | 1 |
| Ryu, DH | 1 |
| Park, S | 1 |
| Hwang, GS | 1 |
| Higuchi, K | 1 |
| Takeuchi, T | 1 |
| Uedo, N | 1 |
| Takeuchi, Y | 1 |
| Naito, Y | 2 |
| Yagi, N | 1 |
| Tominaga, K | 1 |
| Machida, H | 1 |
| Tamada, T | 1 |
| Morita, Y | 2 |
| Yazumi, S | 1 |
| Yamao, J | 1 |
| Iguchi, M | 1 |
| Azuma, T | 2 |
| Xiong, J | 1 |
| Lai, S | 1 |
| Zhang, P | 1 |
| Li, Q | 1 |
| Wei, Y | 1 |
| Wang, T | 1 |
| Liu, L | 1 |
| Ma, X | 1 |
| Chen, D | 1 |
| Tsukamoto, H | 1 |
| Mizoshita, T | 1 |
| Katano, T | 1 |
| Hayashi, N | 1 |
| Ozeki, K | 1 |
| Ebi, M | 1 |
| Shimura, T | 1 |
| Mori, Y | 1 |
| Tanida, S | 1 |
| Kataoka, H | 1 |
| Tsukamoto, T | 1 |
| Tatematsu, M | 1 |
| Joh, T | 1 |
| Han, X | 1 |
| Jiang, K | 1 |
| Wang, B | 1 |
| Zhou, L | 1 |
| Sekiguchi, F | 1 |
| Sekimoto, T | 1 |
| Ogura, A | 1 |
| Kawabata, A | 1 |
| Kang, DW | 3 |
| Noh, YN | 1 |
| Hwang, WC | 2 |
| Choi, KY | 2 |
| Min, do S | 2 |
| Nakamura, K | 1 |
| Ihara, E | 1 |
| Akiho, H | 1 |
| Akahoshi, K | 1 |
| Harada, N | 1 |
| Ochiai, T | 1 |
| Nakamura, N | 1 |
| Ogino, H | 1 |
| Iwasa, T | 1 |
| Aso, A | 1 |
| Iboshi, Y | 1 |
| Takayanagi, R | 1 |
| Calabrese, C | 1 |
| Pisi, A | 1 |
| Di Febo, G | 1 |
| Liguori, G | 1 |
| Filippini, G | 1 |
| Cervellera, M | 1 |
| Righi, V | 1 |
| Lucchi, P | 1 |
| Mucci, A | 1 |
| Schenetti, L | 1 |
| Tonini, V | 1 |
| Tosi, MR | 1 |
| Tugnoli, V | 1 |
| Min, G | 1 |
| Park, DY | 1 |
| Hong, KW | 1 |
| Fujiwara, S | 1 |
| Toyonaga, T | 1 |
| Kawakami, F | 1 |
| Itoh, T | 1 |
| Yoshida, M | 2 |
| Kutsumi, H | 1 |
| Kabeya, M | 1 |
| Ina, K | 1 |
| Yuasa, S | 1 |
| Kikuchi, F | 1 |
| Tajiri, C | 1 |
| Kato, T | 1 |
| Hibi, S | 1 |
| Minagawa, Y | 1 |
| Furuta, R | 1 |
| Kayukawa, S | 1 |
| Kataoka, T | 1 |
| Kawai, M | 1 |
| Kobayashi, M | 1 |
| Takeuchi, M | 1 |
| Hashimoto, S | 1 |
| Mizuno, K | 1 |
| Sato, Y | 1 |
| Narisawa, R | 1 |
| Aoyagi, Y | 1 |
| Shin, WG | 1 |
| Kim, SJ | 1 |
| Choi, MH | 1 |
| Kim, KO | 1 |
| Jang, HJ | 1 |
| Park, CH | 1 |
| Baek, IH | 1 |
| Kim, KH | 1 |
| Baik, GH | 1 |
| Kae, SH | 1 |
| Kim, HY | 1 |
| Park, MH | 1 |
| Ko, GH | 1 |
| Ha, WS | 1 |
| Kim, KS | 1 |
| Min, DS | 1 |
| Hahm, KB | 2 |
| Song, YJ | 1 |
| Oh, TY | 1 |
| Surh, YJ | 1 |
| Kim, YB | 1 |
| Yoo, BM | 1 |
| Han, SU | 1 |
| Nahm, KT | 1 |
| Kim, MW | 1 |
| Kim, DY | 1 |
| Cho, SW | 2 |
| Yoshida, N | 1 |
| Ishikawa, T | 1 |
| Ichiishi, E | 1 |
| Yoshida, Y | 1 |
| Hanashiro, K | 1 |
| Kuchide, M | 1 |
| Uchiyama, K | 1 |
| Kokura, S | 1 |
| Ichikawa, H | 1 |
| Yamamura, Y | 1 |
| Okanoue, T | 1 |
| Yoshikawa, T | 1 |
| Haruma, K | 1 |
| Ito, M | 1 |
| DIETRICH, FS | 1 |
| COPE, C | 1 |
| RIVERS, S | 1 |
| KRANTZ, S | 1 |
| BAUM, G | 1 |
| BECK, HJ | 1 |
| RODENSKY, PL | 1 |
| PIPER, DW | 1 |
| MACOUN, ML | 1 |
| BUILDER, JE | 1 |
| FENTON, BH | 1 |
| Shimada, S | 1 |
| Inoue, K | 1 |
| Kuramoto, M | 1 |
| Suzuki, S | 1 |
| Yamamoto, K | 1 |
| Ogawa, M | 1 |
| Mun, CW | 1 |
| Cho, JY | 1 |
| Shin, WJ | 1 |
| Choi, KS | 1 |
| Eun, CK | 1 |
| Cha, SS | 1 |
| Lee, J | 1 |
| Yang, YI | 1 |
| Nam, SH | 1 |
| Kim, J | 1 |
| Lee, SY | 1 |
| Tarnawski, A | 1 |
| Pai, R | 2 |
| Chiou, SK | 1 |
| Chai, J | 1 |
| Chu, EC | 1 |
| Geddert, H | 1 |
| Kiel, S | 1 |
| Zotz, RB | 1 |
| Willers, R | 1 |
| Gabbert, HE | 1 |
| Sarbia, M | 1 |
| Tanigawa, T | 1 |
| Arakawa, T | 1 |
| Tarnawski, AS | 1 |
| Suganuma, M | 1 |
| Yamaguchi, K | 1 |
| Ono, Y | 1 |
| Matsumoto, H | 1 |
| Hayashi, T | 1 |
| Ogawa, T | 1 |
| Imai, K | 1 |
| Kuzuhara, T | 1 |
| Nishizono, A | 1 |
| Fujiki, H | 1 |
| Abasov, IT | 1 |
| Sauerwein, HP | 1 |
| Michels, RP | 1 |
| Cejka, V | 1 |
| Tatara, T | 1 |
| Noguchi, J | 1 |
| Fukushima, K | 1 |
| Ishihara, Y | 1 |
| Ohkochi, S | 1 |
| Uedaira, H | 1 |
| Yoshida, T | 1 |
| Sato, R | 1 |
| Mahmood, S | 1 |
| Kawasaki, S | 1 |
| Futai, M | 1 |
| Maeda, M | 1 |
| Lee, KJ | 1 |
| Chung, MH | 1 |
| Aihara, M | 1 |
| Azuma, A | 1 |
| Takizawa, H | 1 |
| Tsuchimoto, D | 1 |
| Funakoshi, Y | 1 |
| Shindo, Y | 1 |
| Ohmoto, Y | 1 |
| Imagawa, K | 1 |
| Kikuchi, M | 1 |
| Mukaida, N | 1 |
| Matsushima, K | 1 |
| Masamune, A | 1 |
| Shimosegawa, T | 1 |
| Tamura, Y | 1 |
| Niinobe, M | 1 |
| Arima, T | 1 |
| Okuda, H | 1 |
| Fujii, S | 1 |
| Izawa, M | 1 |
| Takayama, S | 1 |
| Shindo-Okada, N | 1 |
| Doi, S | 1 |
| Kimura, M | 1 |
| Katsuki, M | 1 |
| Nishimura, S | 1 |
| Spellman, CM | 1 |
| Fottrell, PF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Plasma and Urine Metabolomics for Biomarker Discovery in Children With Eosinophilic Esophagitis[NCT03107819] | 24 participants (Actual) | Observational | 2017-03-29 | Completed | |||
| Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection? : Multicenter, Randomized, and Prospective Study[NCT01167101] | 290 participants (Actual) | Interventional | 2009-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for alanine and Stomach Neoplasms
| Article | Year |
|---|---|
Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.
Topics: Adenoma; Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopy, | 2014 |
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?
Topics: Alanine; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cyto | 2003 |
Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide.
Topics: Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticarcinogenic Agents; Gastri | 2003 |
Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide.
Topics: Alanine; Antioxidants; Apoptosis; DNA Damage; Helicobacter Infections; Helicobacter pylori; Humans; | 1998 |
12 trials available for alanine and Stomach Neoplasms
| Article | Year |
|---|---|
Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers.
Topics: Alanine; Anti-Ulcer Agents; Carnosine; Drug Therapy, Combination; Endoscopic Mucosal Resection; Huma | 2021 |
Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
Topics: Alanine; Atrophy; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; | 2022 |
Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
Topics: Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopic Mucosal R | 2019 |
Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers.
Topics: Adenocarcinoma; Aged; Alanine; Anti-Ulcer Agents; Dissection; Female; Gastroscopy; Humans; Iatrogeni | 2013 |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female; | 2015 |
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.
Topics: Alanine; CDX2 Transcription Factor; Disease Progression; Female; Gastric Mucosa; Gastritis; Helicoba | 2015 |
Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
Topics: Adenoma; Aged; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopic Mucosal Resection; | 2016 |
A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine; Anti-Ulcer Agents; Disease Progression; Drug | 2011 |
[Pilot study on clinical effects of rebamipide gargle against oral mucositis induced by fluoropyrimidines].
Topics: Alanine; Antimetabolites, Antineoplastic; Colonic Neoplasms; Fluorouracil; Humans; Mouthwashes; Pilo | 2011 |
Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.
Topics: Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopy, Digestive | 2012 |
Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
Topics: Adenoma; Aged; Alanine; Anti-Ulcer Agents; Carcinoma; Chi-Square Distribution; Confidence Intervals; | 2012 |
Preoperative administration of rebamipide significantly lowers body temperature and circulating interleukin-6 in gastric cancer patients after gastrectomy.
Topics: Aged; Alanine; Chemoprevention; Enzyme Inhibitors; Female; Fever; Gastrectomy; Humans; Interleukin-6 | 2003 |
29 other studies available for alanine and Stomach Neoplasms
| Article | Year |
|---|---|
Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
Topics: Alanine; Aspartic Acid; Glutamates; Humans; Immunotherapy; Metabolomics; Neoadjuvant Therapy; Proteo | 2022 |
Microbiota and metabolites alterations in proximal and distal gastric cancer patients.
Topics: Alanine; Arginine; Aspartic Acid; Feces; Glutamates; Hormones; Humans; Metabolomics; Microbiota; RNA | 2022 |
Surface-Enhanced Raman Scattering Enantioselective Detection of Gastric Cancer-Related d-Amino Acids in Saliva Based on Enzyme-Mediated Cascade Reaction.
Topics: Alanine; Amino Acids; Antifibrinolytic Agents; Humans; Hydrogen Peroxide; Proline; Saliva; Spectrum | 2023 |
Toxicity and structure-activity relationship (SAR) of α,β-dehydroamino acids against human cancer cell lines.
Topics: Alanine; Antineoplastic Agents; Apoptosis; Caspases; Cell Line; Cell Line, Tumor; Cell Shape; Drug D | 2018 |
Chemopreventive Effect of Rebamipide against Gastric Cancer in Patients who undergo Endoscopic Resection for Early Gastric Neoplasms: A Nationwide Claims Study.
Topics: Administrative Claims, Healthcare; Aged; Alanine; Anti-Ulcer Agents; Dose-Response Relationship, Dru | 2019 |
Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Topics: Alanine; Area Under Curve; Arginine; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; C | 2014 |
Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.
Topics: Adenocarcinoma; Alanine; Animals; Antioxidants; Carcinogenesis; Carcinogens; Disease Models, Animal; | 2015 |
Endogenous Hydrogen Sulfide Enhances Cell Proliferation of Human Gastric Cancer AGS Cells.
Topics: Alanine; Alkynes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystathionine gamm | 2016 |
Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Topics: Alanine; Animals; Anticarcinogenic Agents; Antigens, Bacterial; Apoptosis; Bacterial Proteins; beta | 2016 |
Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy.
Topics: Adenocarcinoma; Aged; Alanine; Biomarkers, Tumor; Choline; Endoscopy, Gastrointestinal; Female; Gast | 2008 |
Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.
Topics: Alanine; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplast | 2010 |
Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
Topics: Alanine; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Gene Expression Regulation, Enz | 2013 |
The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
Topics: Alanine; Anti-Ulcer Agents; Chemokine CCL5; Chemokine CXCL2; Down-Regulation; Epithelial Cells; Fibr | 2003 |
Clinical trial with alanine mustard.
Topics: Alanine; Lung Neoplasms; Lymphoma; Mustard Plant; Nitrogen Mustard Compounds; Stomach Neoplasms | 1962 |
NONPROTEOLYTIC ENZYMES IN GASTRIC JUICE.
Topics: Alanine; Alkaline Phosphatase; Anemia; Anemia, Pernicious; Aspartate Aminotransferases; Duodenal Ulc | 1963 |
Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Topics: Adenocarcinoma; Alanine; Choline; Feasibility Studies; Humans; Lipid Metabolism; Magnetic Resonance | 2004 |
Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B.
Topics: Alanine; Aurora Kinase B; Aurora Kinases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relati | 2005 |
Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alanine; Barrett Esophagus; Cardia; Case-Control Stu | 2005 |
Rebamipide inhibits gastric cancer cell growth.
Topics: Alanine; Anti-Ulcer Agents; Cell Proliferation; Cyclin-Dependent Kinases; Extracellular Signal-Regul | 2007 |
TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells.
Topics: Alanine; Animals; Bacterial Proteins; Biomarkers, Tumor; Blotting, Western; Carcinogens; Chronic Dis | 2008 |
Chromatographic analysis of free amino acids of gastric juice in patients with cancer and other stomach diseases.
Topics: Adult; Alanine; Amino Acids; Arginine; Aspartic Acid; Chromatography; Cystine; Duodenal Ulcer; Femal | 1967 |
Alanine turnover in the postabsorptive state and during parenteral hyperalimentation before and after surgery.
Topics: Absorption; Adult; Alanine; Fasting; Female; Humans; Kinetics; Male; Middle Aged; Parenteral Nutriti | 1981 |
Proton NMR spectroscopic studies of serum as an aid to perioperative cellular metabolic monitoring.
Topics: Adult; Aged; Alanine; Blood Chemical Analysis; Blood Glucose; Esophageal Neoplasms; Fatty Acids, Non | 1995 |
GATA-6 DNA binding protein expressed in human gastric adenocarcinoma MKN45 cells.
Topics: Adenocarcinoma; Alanine; Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Conserved Seque | 1997 |
Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.
Topics: Alanine; Anti-Ulcer Agents; Blotting, Northern; DNA Primers; Gene Expression Regulation, Neoplastic; | 1998 |
Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
Topics: Alanine; Anti-Ulcer Agents; Blotting, Northern; Blotting, Western; Ceramides; Enzyme Activation; Enz | 2001 |
Aminopeptidases and arylamidases in normal and cancer tissues in humans.
Topics: Alanine; Amides; Aminopeptidases; Colon; Digestive System; Humans; Ileum; Kidney; Leucine; Liver; Li | 1975 |
Inhibition of chemical carcinogenesis in vivo by azatyrosine.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alanine; Animals; Antibiotics, Antineoplastic; Drug Screening Assa | 1992 |
Similarities between pyruvate kinase from human placenta and tumours.
Topics: Adenosine Triphosphate; Alanine; Carcinoma; Chromatography, Gel; Chromatography, Ion Exchange; Elect | 1973 |